Correlation Between Cognition Therapeutics and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cognition Therapeutics and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognition Therapeutics and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cognition Therapeutics and Seres Therapeutics, you can compare the effects of market volatilities on Cognition Therapeutics and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognition Therapeutics with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognition Therapeutics and Seres Therapeutics.
Diversification Opportunities for Cognition Therapeutics and Seres Therapeutics
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cognition and Seres is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Cognition Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognition Therapeutics are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Cognition Therapeutics i.e., Cognition Therapeutics and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Cognition Therapeutics and Seres Therapeutics
Given the investment horizon of 90 days Cognition Therapeutics is expected to under-perform the Seres Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cognition Therapeutics is 1.11 times less risky than Seres Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Seres Therapeutics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 654.00 in Seres Therapeutics on August 30, 2024 and sell it today you would lose (562.00) from holding Seres Therapeutics or give up 85.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cognition Therapeutics vs. Seres Therapeutics
Performance |
| Timeline |
| Cognition Therapeutics |
| Seres Therapeutics |
Cognition Therapeutics and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cognition Therapeutics and Seres Therapeutics
The main advantage of trading using opposite Cognition Therapeutics and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognition Therapeutics position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Cognition Therapeutics vs. Bright Minds Biosciences | Cognition Therapeutics vs. HP Inc | Cognition Therapeutics vs. Intel | Cognition Therapeutics vs. Chevron Corp |
| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |